My Life On GLP1

Experiencing hunger again after months on Ozempic, Wegovy, or Mounjaro? You're not alone. This episode breaks down why appetite returns during GLP-1 treatment, what it means for your weight loss journ...

8 Des 202510min

My Life on GLP-1 is returning for Series 14 next week! Get the straight facts on weight loss meds, GLP-1 breakthroughs, side effects, success stories, and helpful tips. Whether you're on Ozempic, Moun...

4 Des 20251min

Afraid of weight gain on Thanksgiving despite taking GLP-1 medications like Ozempic, Zepbound, or Mounjaro? You're not alone. Discover why holiday weight gain happens even with weight loss medication,...

19 Nov 202510min

Wearing fleece in 70-degree weather? You're not alone. Discover why semaglutide and tirzepatide cause "Ozempic chill"—from brown adipose tissue changes to metabolic slowdown. Learn 2025 research on hy...

30 Okt 20258min

25-40% of weight lost on semaglutide and tirzepatide comes from muscle, not fat. Learn about sarcopenia, DXA scan data revealing lean mass loss, and 5 essential strategies: protein targets, resistance...

30 Okt 20257min

Why Rhode Island leads 67% growth while Arkansas declines. Map state-by-state, province-by-province GLP-1 adoption patterns across North America and UK. Learn which regions have best access, why postc...

29 Okt 20258min

74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans w...

29 Okt 20256min

12% of Americans have tried GLP-1 medications—but what are they actually experiencing? We break down the stats: 40% get nausea, 73% have GI issues, why women lose hair 14x more than men, and discontin...

28 Okt 20257min